Back to Search
Start Over
373P Safety and efficacy of aumolertinib treatment in patients with advanced NSCLC harboring uncommon EGFR mutations: Cohort 2.
- Source :
-
Annals of Oncology . Nov2022 Suppl 9, Vol. 33, pS1587-S1588. 2p. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 160398311
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.10.411